Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
InspireMD ( (NSPR) ) has issued an update.
InspireMD has appointed Scott R. Ward, a seasoned executive with a rich history in medical technology and a track record of growth and innovation, to its Board of Directors. This strategic move is expected to leverage Ward’s extensive experience in the cardiovascular field as InspireMD gears up for potential U.S. approval of its groundbreaking CGuard Prime stent system, anticipated to set a new standard in carotid intervention and stroke prevention.
See more insights into NSPR stock on TipRanks’ Stock Analysis page.
